Interleukin-12: Biological Properties and Clinical Application
Michele Del Vecchio(Fondazione IRCCS Istituto Nazionale dei Tumori), Andrea Anichini(Fondazione IRCCS Istituto Nazionale dei Tumori), Michael T. Lotze(University of Pittsburgh), Stefania Canova, Amy Wesa, Giorgio Parmiani(Fondazione IRCCS Istituto Nazionale dei Tumori), Emilio Bajetta(Fondazione Lanza)
Cited by 606
Related Papers
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
|New England Journal of Medicine|2017|2.2k
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
|New England Journal of Medicine|2004|1.8k
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k